Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beau R Webber

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Stem Cells and Development|August 20, 2016
CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi AnemiaMark Osborn, Cara-Lin Lonetree, Beau R Webber, et al.
Journal of Inherited Metabolic Disease|October 16, 2016
Angiotensin receptor blockade mediated amelioration of mucopolysaccharidosis type I cardiac and craniofacial pathologyMark J Osborn, Beau R Webber, Ronald T McElmurry, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Efficient multiplex non-viral engineering and expansion of polyclonal γδ CAR-T cells for immunotherapyJacob Bridge, Matthew J Johnson, Jihyun Kim, et al.
Molecular Therapy. Advances|May 25, 2026
Efficient, fratricide free non-viral engineering of CD70-targeted CAR NK cells for hematologic and solid tumor immunotherapyJae-Woong Chang, Joshua Krueger, Timothy D Folsom, et al.
The CRISPR Journal|August 16, 2022
Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing TechnologiesKelsie L Becklin, Garrett M Draper, Rebecca A Madden, et al.
Blood|May 24, 2017
Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cellsMathew G Angelos, Paige N Ruh, Beau R Webber, et al.
Molecular Genetics and Metabolism|April 6, 2023
Generation and characterization of an immunodeficient mouse model of mucopolysaccharidosis type IIMiles C Smith, Lalitha R Belur, Andrea D Karlen, et al.
Blood|September 4, 2025
Leukemia escapes immunity by imposing a type 1 regulatory program on neoantigen-specific CD4+ T cellsHrishi Venkatesh, Enoc Granados Centeno, Qianyun Luo, et al.
Nature Communications|February 1, 2023
Germline T cell receptor exchange results in physiological T cell development and functionMeagan R Rollins, Jackson F Raynor, Ebony A Miller, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Engineering "physically optimized" T cells for increased sampling of complex tumor microenvironmentsHongrong Zhang, Zhongming Chen, Guhan Qian, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Stem Cells and Development|August 20, 2016
CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi AnemiaMark Osborn, Cara-Lin Lonetree, Beau R Webber, et al.
Journal of Inherited Metabolic Disease|October 16, 2016
Angiotensin receptor blockade mediated amelioration of mucopolysaccharidosis type I cardiac and craniofacial pathologyMark J Osborn, Beau R Webber, Ronald T McElmurry, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Efficient multiplex non-viral engineering and expansion of polyclonal γδ CAR-T cells for immunotherapyJacob Bridge, Matthew J Johnson, Jihyun Kim, et al.
Molecular Therapy. Advances|May 25, 2026
Efficient, fratricide free non-viral engineering of CD70-targeted CAR NK cells for hematologic and solid tumor immunotherapyJae-Woong Chang, Joshua Krueger, Timothy D Folsom, et al.
The CRISPR Journal|August 16, 2022
Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing TechnologiesKelsie L Becklin, Garrett M Draper, Rebecca A Madden, et al.
Blood|May 24, 2017
Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cellsMathew G Angelos, Paige N Ruh, Beau R Webber, et al.
Molecular Genetics and Metabolism|April 6, 2023
Generation and characterization of an immunodeficient mouse model of mucopolysaccharidosis type IIMiles C Smith, Lalitha R Belur, Andrea D Karlen, et al.
Blood|September 4, 2025
Leukemia escapes immunity by imposing a type 1 regulatory program on neoantigen-specific CD4+ T cellsHrishi Venkatesh, Enoc Granados Centeno, Qianyun Luo, et al.
Nature Communications|February 1, 2023
Germline T cell receptor exchange results in physiological T cell development and functionMeagan R Rollins, Jackson F Raynor, Ebony A Miller, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Engineering "physically optimized" T cells for increased sampling of complex tumor microenvironmentsHongrong Zhang, Zhongming Chen, Guhan Qian, et al.
Pageof 8